CIK 0001367644
- Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 141902018
- Phone
- +1 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-08-31 | El-Hibri Fuad Chairman | Sale | −5,461 | $37.50 | $205K | 1,624,755 |
| 2017-08-15 | Hauer Jerome M Director | Grant or award | +5,153 | $25.47 | $131K | 29,421 |
| 2017-08-15 | Hauer Jerome M Director | Sale | −10,776 | $35.83 | $386K | 18,645 |
| 2017-08-15 | Hauer Jerome M Director | Exercise or conversion · Stock Option (Right to Buy) | −5,153 | 5,152 | ||
| 2017-08-08 | SARAN ATUL EVP, Corp Dev, GC & Secretary | Grant or award | +12,814 | 12,814 | ||
| 2017-08-08 | SARAN ATUL EVP, Corp Dev, GC & Secretary | Grant or award · Employee stock option (right to buy) | +20,083 | 20,083 | ||
| 2017-07-27 | El-Hibri Fuad Chairman | Sale | −25,000 | $36.50 | $913K | 1,630,216 |
Page 45 of 45 · 887 trades